Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other Non-Current Assets (2016 - 2026)

Cytosorbents filings provide 16 years of Other Non-Current Assets readings, the most recent being $1.5 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 2.56% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 2.56% increase, with the full-year FY2025 number at $1.5 million, up 2.56% from a year prior.
  • Other Non-Current Assets hit $1.5 million in Q4 2025 for Cytosorbents, down from $3.6 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.5 million in Q2 2024 to a low of $1.5 million in Q4 2023.
  • Median Other Non-Current Assets over the past 5 years was $4.1 million (2023), compared with a mean of $3.5 million.
  • Biggest five-year swings in Other Non-Current Assets: surged 9082.55% in 2021 and later tumbled 76.53% in 2025.
  • Cytosorbents' Other Non-Current Assets stood at $5.0 million in 2021, then decreased by 10.51% to $4.4 million in 2022, then plummeted by 66.56% to $1.5 million in 2023, then rose by 0.0% to $1.5 million in 2024, then increased by 2.56% to $1.5 million in 2025.
  • The last three reported values for Other Non-Current Assets were $1.5 million (Q4 2025), $3.6 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.